These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17017505)

  • 1. Bad oscillations in Parkinson's disease.
    Brown P
    J Neural Transm Suppl; 2006; (70):27-30. PubMed ID: 17017505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease.
    Weinberger M; Mahant N; Hutchison WD; Lozano AM; Moro E; Hodaie M; Lang AE; Dostrovsky JO
    J Neurophysiol; 2006 Dec; 96(6):3248-56. PubMed ID: 17005611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal ganglia local field potential activity: character and functional significance in the human.
    Brown P; Williams D
    Clin Neurophysiol; 2005 Nov; 116(11):2510-9. PubMed ID: 16029963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive timing functions of cortical beta oscillations are impaired in Parkinson's disease and influenced by L-DOPA and deep brain stimulation of the subthalamic nucleus.
    Gulberti A; Moll CK; Hamel W; Buhmann C; Koeppen JA; Boelmans K; Zittel S; Gerloff C; Westphal M; Schneider TR; Engel AK
    Neuroimage Clin; 2015; 9():436-49. PubMed ID: 26594626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pallidal Deep-Brain Stimulation Disrupts Pallidal Beta Oscillations and Coherence with Primary Motor Cortex in Parkinson's Disease.
    Wang DD; de Hemptinne C; Miocinovic S; Ostrem JL; Galifianakis NB; San Luciano M; Starr PA
    J Neurosci; 2018 May; 38(19):4556-4568. PubMed ID: 29661966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological subthalamic nucleus oscillations in PD: can they be the cause of bradykinesia and akinesia?
    Weinberger M; Hutchison WD; Dostrovsky JO
    Exp Neurol; 2009 Sep; 219(1):58-61. PubMed ID: 19460368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of L-Dopa on the pattern of movement-related (de)synchronisation in advanced Parkinson's disease.
    Devos D; Labyt E; Derambure P; Bourriez JL; Cassim F; Guieu JD; Destée A; Defebvre L
    Neurophysiol Clin; 2003 Nov; 33(5):203-12. PubMed ID: 14672820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of deep brain stimulation and L-Dopa on electrocortical rhythms related to movement in Parkinson's disease.
    Devos D; Defebvre L
    Prog Brain Res; 2006; 159():331-49. PubMed ID: 17071241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encoding of sequence boundaries in the subthalamic nucleus of patients with Parkinson's disease.
    Herrojo Ruiz M; Rusconi M; Brücke C; Haynes JD; Schönecker T; Kühn AA
    Brain; 2014 Oct; 137(Pt 10):2715-30. PubMed ID: 25031238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The network of causal interactions for beta oscillations in the pedunculopontine nucleus, primary motor cortex, and subthalamic nucleus of walking parkinsonian rats.
    Li M; Zhou M; Wen P; Wang Q; Yang Y; Xiao H; Xie Z; Li X; Wang N; Wang J; Luo F; Chang J; Zhang W
    Exp Neurol; 2016 Aug; 282():27-36. PubMed ID: 27163550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High beta activity in the subthalamic nucleus and freezing of gait in Parkinson's disease.
    Toledo JB; López-Azcárate J; Garcia-Garcia D; Guridi J; Valencia M; Artieda J; Obeso J; Alegre M; Rodriguez-Oroz M
    Neurobiol Dis; 2014 Apr; 64():60-5. PubMed ID: 24361601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional and effective connectivity in subthalamic local field potential recordings of patients with Parkinson's disease.
    Hohlefeld FU; Huchzermeyer C; Huebl J; Schneider GH; Nolte G; Brücke C; Schönecker T; Kühn AA; Curio G; Nikulin VV
    Neuroscience; 2013 Oct; 250():320-32. PubMed ID: 23876322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency dependent effects of subthalamic nucleus stimulation in Parkinson's disease.
    Fogelson N; Kühn AA; Silberstein P; Limousin PD; Hariz M; Trottenberg T; Kupsch A; Brown P
    Neurosci Lett; 2005 Jul 1-8; 382(1-2):5-9. PubMed ID: 15911112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oscillatory subthalamic nucleus activity is modulated by dopamine during emotional processing in Parkinson's disease.
    Huebl J; Spitzer B; Brücke C; Schönecker T; Kupsch A; Alesch F; Schneider GH; Kühn AA
    Cortex; 2014 Nov; 60():69-81. PubMed ID: 24713195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypersynchrony despite pathologically reduced beta oscillations in patients with Parkinson's disease: a pharmaco-magnetoencephalography study.
    Heinrichs-Graham E; Kurz MJ; Becker KM; Santamaria PM; Gendelman HE; Wilson TW
    J Neurophysiol; 2014 Oct; 112(7):1739-47. PubMed ID: 25008416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 300-Hz subthalamic oscillations in Parkinson's disease.
    Foffani G; Priori A; Egidi M; Rampini P; Tamma F; Caputo E; Moxon KA; Cerutti S; Barbieri S
    Brain; 2003 Oct; 126(Pt 10):2153-63. PubMed ID: 12937087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhythm-specific pharmacological modulation of subthalamic activity in Parkinson's disease.
    Priori A; Foffani G; Pesenti A; Tamma F; Bianchi AM; Pellegrini M; Locatelli M; Moxon KA; Villani RM
    Exp Neurol; 2004 Oct; 189(2):369-79. PubMed ID: 15380487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroencephalographic lateralization, clinical correlates and pharmacological response in untreated Parkinson's disease.
    Mostile G; Nicoletti A; Dibilio V; Luca A; Pappalardo I; Giuliano L; Cicero CE; Sciacca G; Raciti L; Contrafatto D; Bruno E; Sofia V; Zappia M
    Parkinsonism Relat Disord; 2015 Aug; 21(8):948-53. PubMed ID: 26096796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of Medication on the Oscillatory and Dynamic Characteristics of Subthalamic Local Field Potentials in Patients with Parkinson's Disease].
    Wang Y; Geng X; Huang Y; Wang S
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2016 Feb; 33(1):49-55. PubMed ID: 27382739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential modulation of STN-cortical and cortico-muscular coherence by movement and levodopa in Parkinson's disease.
    Hirschmann J; Özkurt TE; Butz M; Homburger M; Elben S; Hartmann CJ; Vesper J; Wojtecki L; Schnitzler A
    Neuroimage; 2013 Mar; 68():203-13. PubMed ID: 23247184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.